Comorbidity in older surgical cancer patients: Influence on patient care and outcome
Introduction
Due to ageing of the population and rising incidence rates of most cancers with age, the mean age of patients diagnosed with cancer is increasing in western countries. This implies that patients increasingly suffer from one or more other serious (chronic) diseases, especially cardiovascular diseases, COPD, hypertension or diabetes.1 Besides affecting life expectancy, comorbid conditions may complicate major surgery in cancer patients, especially when they are frail.2, 3, 4, 5, 6 Surgery is the only curative treatment option for patients with colorectal cancer, stage I–II non-small cell lung cancer (NSCLC) or breast cancer. Until now, there is lacking evidence about the influence of specific comorbid conditions on outcome of surgery as these elderly patients are often excluded from clinical trials. This information, however, is highly relevant for estimating the surgical risk of cancer patients, and for optimising pre-, peri- and postoperative care. Choice for surgery is clearly different among the different tumour groups. Generally speaking, surgery for colorectal cancer is often preferable because of bleeding or obstruction and the intention to perform a curative procedure (although in a non-curative setting alternative procedures are present). Surgery among lung cancer patients is high risk surgery, and radiotherapy is an alternative. Therefore, there is a strict selection of surgery among lung cancer patients. Surgery for breast cancer is low risk, but among older patients hormonal treatment is an alternative, which means that there is a more ‘elective’ selection.
In this paper, we summarise our findings with respect to the prognostic role of increasing age and comorbid conditions in patients diagnosed with stage I–III colorectal, stage I–II NSCLC or stage I–III breast cancer in the registration area of the population-based Eindhoven Cancer Registry, and discuss them against the background of the literature.
Section snippets
Patients and methods
The Eindhoven Cancer Registry records data on all patients newly diagnosed with cancer in the southern part of the Netherlands, an area with 2.3 million inhabitants and only with general hospitals. Since 1993, serious comorbidity with prognostic impact has been recorded for all patients. The Charlson comorbidity index is most widely used for recording comorbidity and was validated in various studies.7 We used a slightly modified version of this index for recording comorbidity. Comorbidity was
Surgery
Table 1 shows the general characteristics and resection rates of the patients.
Almost all patients with stage I–III colon cancer and stage I–III rectal cancer underwent surgery regardless of age or comorbidity (Fig. 1a and b). The proportion of patients with stage I–II NSCLC who underwent surgery was only 15% of those aged 80 or older versus 88% of age group 50–64 and 67% of those aged 65–79 (P < 0.01) (Fig. 1c). Among patients up to 80 years, the resection rate was significantly lower when COPD,
Surgery
When surgery is inevitable, like in patients with colorectal cancer, higher age or the prevalence of comorbidity did not significantly affect the resection rate. Surgery is the cornerstone for cure. Its goal is also to gain immediate relief of symptoms. Treatment options that do not focus on immediate relief of symptoms were, however, less applied in the elderly: several previous studies have shown that elderly patients with stage III colon carcinoma received less adjuvant chemotherapy and
Conclusions
Our study emphasises that comorbidity primarily has an impact on overall survival and less on postoperative complications, although high rates of postoperative complications remain. Comorbidity also leads to withholding surgical interventions if surgical therapy is commonly recognised as ‘high risk’ (e.g. stage I–II NSCLC) or if alternative non-surgical treatment is available (e.g. stage I–III breast cancer). Previous studies have shown that operative risk is especially high among colorectal
Take home messages
- 1.
Patients with comorbidity often have a poorer survival
- 2.
Anticipate postoperative complications in case of:
- (a)
(Elderly) colorectal cancer patients with reduced pulmonary function, cardiovascular diseases or neurological comorbidity.
- (b)
(Elderly) NSCLC patients with reduced pulmonary function or cardiovascular diseases.
- (a)
- 3.
Prospective studies are needed for evaluating:
- (a)
Screening tools or selection criteria for surgery in elderly or those with comorbidity.
- (b)
Complications and recurrence rates in elderly cancer
- (a)
Conflict of interest statement
None declared.
Acknowledgements
This work was carried out with grants from the Dutch Cancer Society (IKZ 2000-2260).
References (67)
- et al.
Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach
Crit Rev Oncol Hematol
(2005) - et al.
Surgical lung cancer. Risk operative analysis
Lung Cancer
(2004) - et al.
Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends
Ann Thorac Surg
(2006) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chronic Dis
(1987) - et al.
A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data
J Clin Epidemiol
(1999) - et al.
Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity
Ann Oncol
(2005) - et al.
Neoadjuvant treatment for locally advanced rectal carcinoma
Crit Rev Oncol Hematol
(2004) - et al.
Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer
Crit Rev Oncol Hematol
(2006) - et al.
Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study
Eur J Cancer
(2005) - et al.
The consequence of undertreating breast cancer in the elderly
J Am Coll Surg
(2001)
Factors influencing treatment patterns of breast cancer patients age 75 and older
Crit Rev Oncol Hematol
The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: a population-based study
Eur J Cancer
Resection for lung cancer in the elderly patient
Thorac Surg Clin
Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical condition
Chest
Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study
Lung Cancer
Comorbid illnesses and health care utilization among Medicare beneficiaries with lung cancer
Crit Rev Oncol Hematol
A case-mix model for monitoring of postoperative mortality after surgery for lung cancer
Lung Cancer
Anesthesia for breast cancer surgery in the elderly
Crit Rev Oncol Hematol
Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service
J Am Coll Surg
Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogenico de la Sociedad Espanola de Neumologia y Cirugia Toracica
Ann Thorac Surg
Prognostic models of thirty-day mortality and morbidity after major pulmonary resection
J Thorac Cardiovasc Surg
Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC
Lung Cancer
Poor results after surgery for bronchioloalveolar carcinoma
Eur J Surg Oncol
Pulmonary resection in octogenarians with stage I non-small cell lung cancer: a 22-year experience
Ann Thorac Surg
Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer
J Thorac Cardiovasc Surg
Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study
Eur J Cancer
Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer
Int J Radiat Oncol Biol Phys
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus
J Chronic Dis
Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale
Psychiatry Res
A comprehensive geriatric assessment (CGA) is necessary for the study and the management of cancer in the elderly
Eur J Cancer
Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older
JAMA
Comorbidity and functional status are independent in older cancer patients
J Clin Oncol
Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study
J Clin Oncol
Cited by (211)
Gastric adenocarcinoma location and postoperative complication rates in Asian patients: A 2014–2019 NSQIP analysis
2024, American Journal of SurgeryPeritoneal metastases in elderly patients with colorectal cancer
2022, European Journal of Surgical OncologySurgical under-treatment of older adult patients with cancer: A systematic review and meta-analysis
2022, Journal of Geriatric OncologyThe Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease
2022, Seminars in Radiation OncologyReal-world implementation of a geriatric-specific ERAS protocol in patients undergoing colonic cancer surgery
2021, European Journal of Surgical Oncology